Moreover, we show that epigenetic activation of SLFN11 in lymphomas of GCB origin enhances their susceptibility to the clinical DNA-damaging agent cytosine arabinoside, which targets DNA replication. This evidence concerns the gene SLFN11 and lymphoma.